Loading patent…
AssigneeHangzhou Tianlong Pharmaceutical Co., Ltd.
InventorsGengshen Song, Kai Dong, Zhongbin Chen, Yanfen Li, Yuting Zhou, Jing Li, Xin Chai, Zhongcai Gao, Jinyu Zhang, Huanyu Wang
Estimating the term…
The present disclosure belongs to the technical field of mRNA vaccines, and specifically relates to a herpes zoster mRNA vaccine, a preparation method therefor, and a use thereof. The herpes zoster mRNA vaccine provided by the present disclosure comprises an RNA encoding a varicella-zoster virus gE glycoprotein or a variant thereof. The vaccine can prevent herpes zoster infection and its complications.
An immunogenic composition, comprising a ribonucleic acid (RNA) of a varicella-zoster virus (VZV) encoding a variant of the wild-type VZV gE glycoprotein;
Dependencies are inferred from the claim text.